Join now

Already a member? Sign in

Welcome to Inspire!

What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.

Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.

How - Joining Inspire is completely free and usually takes less than a minute. Join now!

corner corner corner

New Treatment for Tumors........

0 Recommendations

Light Sciences lines up $35M in credit, financing
November 6, 2009 — 11:42am ET | By Maureen Martino

Free newsletter via e-mail
Related Stories

* LSO rounds up $40M in third venture round
* Light Sciences Oncology - Top 20 VC deals of 2008

Tools

* Email
* Print
* Comment
* Contact Author
* Reprint

Bellevue, WA-based Light Sciences Oncology has garnered itself a $23.3 million line of credit, in addition to another $11.8 million in warrants. This comes after the company raised $40 million in venture capital in June 2008.

LSO is developing a medical device/drug combination that could treat malignant tumors without killing healthy surrounding tissue. The procedure involves inserting a light-emitting diode into tumors along with talaporfin sodium, an inactive chemical. When the light is turned on, it activates the chemical and destroys the cancer cells. The company began a late-stage trial of the drug for liver cancer in 2006. Although results from that study have yet to be released, LSO has already begun other trials in children with neurofibromatosis and men with enlarged prostates.

- here's the report from Xconomy

Read more: http://www.fiercebiotech.com/story/light-sciences-lines-35m-credit-financin g/2009-11-06#ixzz0WBaLOoIZ

Explore topics in this discussion:

Cancer Neurofibromatosis Liver cancer

1 reply

Photodynamic therapy has been underway for a little while...haven't heard much in first hand results but hopefully we will soon. I think the potential is huge and the side effects seem quite minimal. The research for this for non-NF stuff is more advanced and there have been some amazing stories out of the UK in particular. Very encouraging.

Cindy

Add to the discussion

Don't have an Inspire account? Join now!

Forgot password?

Group leaders

You